128 related articles for article (PubMed ID: 15036553)
1. A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain.
Pérez de los Cobos J; Fidel G; Escuder G; Haro G; Sánchez N; Pascual C; Valderrama JC; Valero S; Trujols J
Drug Alcohol Depend; 2004 Mar; 73(3):307-13. PubMed ID: 15036553
[TBL] [Abstract][Full Text] [Related]
2. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
[TBL] [Abstract][Full Text] [Related]
3. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
4. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
[TBL] [Abstract][Full Text] [Related]
5. Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT).
de los Cobos J; Valero S; Haro G; Fidel G; Escuder G; Trujols J; Valderrama JC
Drug Alcohol Depend; 2002 Oct; 68(2):209-14. PubMed ID: 12234650
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
Madden A; Lea T; Bath N; Winstock AR
Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
[TBL] [Abstract][Full Text] [Related]
7. A satisfaction survey of opioid-dependent patients with methadone maintenance treatment.
Aziz Z; Chong NJ
J Subst Abuse Treat; 2015 Jun; 53():47-51. PubMed ID: 25616750
[TBL] [Abstract][Full Text] [Related]
8. Methadone dosage and retention: an examination of the 60 mg/day threshold.
Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
Rácz J; Melles K; Márványkövi F; Vadász V
Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
[TBL] [Abstract][Full Text] [Related]
10. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
11. Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment.
Sell L; Zador D
Addiction; 2004 Apr; 99(4):442-9. PubMed ID: 15049744
[TBL] [Abstract][Full Text] [Related]
12. An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia.
McAnulty JM; Jauncey ME; Monger CK; Hailstone ST; Alam NK; Mannes TF; Capon AG; Irvine K; Armstrong PK; Kaldor JM
Drug Alcohol Rev; 2007 May; 26(3):321-31. PubMed ID: 17454022
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of first 8 pilot methadone maintenance treatment clinics in China].
Pang L; Mi GD; Wang CH; Luo W; Rou KM; Li JH; Wu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):2-4. PubMed ID: 17429519
[TBL] [Abstract][Full Text] [Related]
14. Access to treatment-related and support services in methadone treatment programs.
Berkman ND; Wechsberg WM
J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
[TBL] [Abstract][Full Text] [Related]
15. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
17. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
18. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment.
Trujols J; Siñol N; de los Cobos JP
J Clin Psychopharmacol; 2010 Feb; 30(1):95-6; author reply 96. PubMed ID: 20075667
[No Abstract] [Full Text] [Related]
20. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
